Literature DB >> 2596484

Prevalence of silicosis at death in underground coal miners.

F H Green1, R Althouse, K C Weber.   

Abstract

This study was initiated by the National Institute for Occupational Safety and Health (NIOSH) and the Bureau of Mines (BOM) to determine the prevalence and pathological features of silicosis in coal miners. The population base was 3,365 autopsied underground miners whose records were submitted to the U.S. National Coal Workers' Autopsy Study between 1971 and 1980. This program is voluntary and covers an estimated 10% of all coal workers who die. The mean age at death of the population was 62 years, of whom 75% were current or ex-smokers at the time of death. The average work tenure was 26 years. Lung sections from all cases were reviewed and the type and severity of pneumoconiosis documented. These findings were correlated with years of mining, job history, and geographic location of mine. Classical silicotic nodules were found in 12.5% of the population. There was a significant relationship between length of underground mining and prevalence and severity of silicosis consistent with a dose-response effect. The study also showed that job category and geographic location of the mine were important determinants of silicosis prevalence and that silicosis was strongly associated with higher categories of coal workers' pneumoconiosis.

Entities:  

Mesh:

Year:  1989        PMID: 2596484     DOI: 10.1002/ajim.4700160601

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  Enhancement of nitric oxide production by pulmonary cells following silica exposure.

Authors:  V Castranova; L J Huffman; D J Judy; J E Bylander; L N Lapp; S L Weber; J A Blackford; R D Dey
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

2.  Mortality and morbidity in populations in the vicinity of coal mining: a systematic review.

Authors:  Javier Cortes-Ramirez; Suchithra Naish; Peter D Sly; Paul Jagals
Journal:  BMC Public Health       Date:  2018-06-11       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.